1401464-30-9

Upstream product

• 1131-16-4 3,5-dimethyl-1-phenyl-1H-pyrazole 

Downstream Products

• 1401464-32-1 C₁₄H₁₆N₂O₂Se 
• 1401464-34-3 C₁₃H₁₆N₂OSe 
• 1401464-35-4 C₁₄H₁₈N₂OSe 
• 1401464-36-5 2-(2-(3,5-dimethyl-1H-pyrazo-1-yl)phenylselenyl)ethanamine 
• 1401464-37-6 C₁₄H₁₉N₃Se 
• 1401464-38-7 2-(3,5-dimethylpyrazol-1-yl)phenylselenyl chloride 
• 1401464-39-8 2-(3,5-dimethylpyrazol-1-yl)phenylselenyl bromide 
• 1401464-40-1 C₁₁H₁₁IN₂Se 
• 1401464-31-0 bis[2-(3,5-dimethylpyrazol-1-yl)phenyl]diselenide 

Relevant academic research and scientific papers

Synthesis, characterization, and X-ray structures of 2-(3,5 - Dimethylpyrazol-1-yl)phenyl-based organoselenium compounds and their glutathione peroxidase (GP X) like activity

The synthesis of a series of 2-(3,5-dimethylpyrazol-1-yl)phenyl-based organoselenium compounds, (dmpzC6H4Se)2 (1), dmpzC6H4SeR (dmpz = 3,5-dimethylpyrazol-1-yl; R = (CH2)nY; Y = OH, NH2, and COOH), and dmpzC6H4SeX (X = Cl, Br, or I) is described. The comp

Synthesis, characterization, structures and cytotoxicity of platinum(II) complexes containing dimethylpyrazole based selenium ligands

A series of water soluble platinum(II) complexes of general formulae [Pt(en)(L)][NO3]2, [Pt(NH3)2(L)][NO3]2 [en = ethylenediamine; L = dmpzC6H4Se(CH2)nCOOH or dmpzCH2CH2Se(CH2)nCOOH (n = 1 and 2)], [Pt(en)(L)][NO3][OH]·H2O [L = dmpzCH2CH2Se(CH2)nCOOH (n = 1 and 2)] and [Pt(dmpzCH2CH2SeCH2CH2COOH)2][Cl]2·2H2O have been synthesized. They were characterized by microanalyses, IR, NMR (1H, 13C{1H}, 77Se{1H} and 195Pt{1H}) spectroscopy. Molecular structures of [Pt(en)(dmpzCH2CH2SeCH2COOH)][NO3][OH]·H2O and [Pt(dmpzCH2CH2SeCH2CH2COOH)2][Cl]2·2H2O were determined unambiguously by single crystal X-ray diffraction analyses. The cytotoxicity of these complexes has been evaluated against human colon (HT29, Colo205), ovarian (A2780) and bladder (T24) cancer cell lines and compared with the activity of cisplatin and adriamycin.